Abstract:Background/Aims: Aberrant activation of the Wnt/β-catenin signaling pathway plays a key role in the pathogenesis of multiple tumors including digestive cancers. Recent studies have reported that Dickkopf-related protein 2 (DKK2) is epigenetically inactivated in numerous types of cancers and that its gene products exhibit tumor-suppressive properties. However, the biological functions and underlying molecular mechanisms of DKK2 in colon carcinoma remains obscure. Methods: We examined the expression of DKK2 in colon tumor cell lines by RT-PCR and its promoter methylation status in colon tumor cell lines and primary tumors by methylation-specific PCR (MSP). Ectopic expression of DKK2 was measured by RT-PCR prior to the other experiments. To investigate the function of DKK2, we assayed colony formation and cell proliferation, utilized flow cytometric analyses of the cell cycle and acridine orange/ethidium bromide (AO/EB) fluorescence staining for apoptosis, and examined wound healing, transwell migration and tumor growth in vivo. Western blots were used to explore the mechanisms of DKK2 in epithelial- mesenchymal transition and canonical Wnt/β-catenin signaling. Results: We show here that downregulation or silencing of DKK2 was closely associated with the hypermethylation status of its promoter and that DKK2 expression could be restored by demethylation treatment. Methylation of the DKK2 promoter was detected in nearly all tumors and tumor-adjacent tissues, but not in normal colon tissues. Ectopic expression of DKK2 in colon cell lines HCT116 and HT-29 inhibited colony formation and cell viability by inducing cell cycle G0/G1 arrest and apoptosis, and growth of stable DKK2-infected HCT116 cells in nude mice was decreased compared to controls. Furthermore, DKK2 restrained cell migration through partial reversal of epithelial-to- mesenchymal transition and also by downregulating several stem cell markers. Our data further showed that restoration of DKK2 expression resulted in downregulation of active β-catenin and its downstream target genes. Conclusion: DKK2 appears to be a functional tumor suppressor regulating tumorigenesis of colorectal cancer by antagonizing Wnt/β-catenin signaling.

CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression

Achaete Scute-Like 2 Suppresses CDX2 Expression and Inhibits Intestinal Neoplastic Epithelial Cell Differentiation.

CDX2 Inhibits Epithelial–mesenchymal Transition in Colorectal Cancer by Modulation of Snail Expression and Β-Catenin Stabilisation Via Transactivation of PTEN Expression

Targeted CDX2 Expression Inhibits Aggressive Phenotypes of Colon Cancer Cells in Vitro and in Vivo.

CBLN2 Overexpression Inhibits Colorectal Cancer Progression and Improves Immunotherapy Responses

Overexpression of caudal‑related homeobox transcription factor 2 inhibits the growth of transplanted colorectal tumors in nude mice

CDX2 As a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis Through EMT in Colorectal Cancer.

Bex2 Promotes Tumor Proliferation In Colorectal Cancer

Effects of CDX2 on Proliferation and Glucose Metabolism Reprogram by Targeting PGAM1 in Colorectal Cancer.

Nuclear Transcription Factor Cdx2 Inhibits Gastric Cancer-Cell Growth and Reverses Epithelial-To-Mesenchymal Transition in Vitro and in Vivo

Impact of CDX2 gene interference on growth of colon cancer cells in nude mice

Effects of Homeodomain Protein CDX2 Expression on the Proliferation and Migration of Lovo Colon Cancer Cells.

Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling

CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways

Silencing Of Brain-Expressed X-Linked 2 (Bex2) Promotes Colorectal Cancer Metastasis Through The Hedgehog Signaling Pathway

Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells

CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo

CDX2 Serves As a Wnt Signaling Inhibitor and is Frequently Methylated in Lung Cancer

SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer

JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level

Canonical Wnt Suppressor, Axin2, Promotes Colon Carcinoma Oncogenic Activity